Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)

Hans-Georg Schnürch; Sven Ackermann; Celine D Alt-Radtke; Lukas Angleitner; Jana Barinoff; Matthias W Beckmann; Carsten Böing; Christian Dannecker; Tanja Fehm; Rüdiger Gaase; Paul Gass; Marion Gebhardt; Friederike Gieseking; Andreas Günthert; Carolin C Hack; Peer Hantschmann; Lars Christian Horn; Martin C Koch; Anne Letsch; Peter Mallmann; Bernhard Mangold; Simone Marnitz; Grit Mehlhorn; Kerstin Paradies; Michael J Reinhardt; Reina Tholen; Uwe Torsten; Wolfgang Weikel; Linn Wölber; Monika Hampl

doi:10.1055/a-0919-4959

Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)

Standard

Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018). / Schnürch, Hans-Georg; Ackermann, Sven; Alt-Radtke, Celine D; Angleitner, Lukas; Barinoff, Jana; Beckmann, Matthias W; Böing, Carsten; Dannecker, Christian; Fehm, Tanja; Gaase, Rüdiger; Gass, Paul; Gebhardt, Marion; Gieseking, Friederike; Günthert, Andreas; Hack, Carolin C; Hantschmann, Peer; Horn, Lars Christian; Koch, Martin C; Letsch, Anne; Mallmann, Peter; Mangold, Bernhard; Marnitz, Simone; Mehlhorn, Grit; Paradies, Kerstin; Reinhardt, Michael J; Tholen, Reina; Torsten, Uwe; Weikel, Wolfgang; Wölber, Linn; Hampl, Monika.

in: GEBURTSH FRAUENHEILK, Jahrgang 79, Nr. 10, 10.2019, S. 1060-1078.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Schnürch, H-G, Ackermann, S, Alt-Radtke, CD, Angleitner, L, Barinoff, J, Beckmann, MW, Böing, C, Dannecker, C, Fehm, T, Gaase, R, Gass, P, Gebhardt, M, Gieseking, F, Günthert, A, Hack, CC, Hantschmann, P, Horn, LC, Koch, MC, Letsch, A, Mallmann, P, Mangold, B, Marnitz, S, Mehlhorn, G, Paradies, K, Reinhardt, MJ, Tholen, R, Torsten, U, Weikel, W, Wölber, L & Hampl, M 2019, 'Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)', GEBURTSH FRAUENHEILK, Jg. 79, Nr. 10, S. 1060-1078. https://doi.org/10.1055/a-0919-4959

APA

Schnürch, H-G., Ackermann, S., Alt-Radtke, C. D., Angleitner, L., Barinoff, J., Beckmann, M. W., Böing, C., Dannecker, C., Fehm, T., Gaase, R., Gass, P., Gebhardt, M., Gieseking, F., Günthert, A., Hack, C. C., Hantschmann, P., Horn, L. C., Koch, M. C., Letsch, A., ... Hampl, M. (2019). Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018). GEBURTSH FRAUENHEILK, 79(10), 1060-1078. https://doi.org/10.1055/a-0919-4959

Vancouver

Schnürch H-G, Ackermann S, Alt-Radtke CD, Angleitner L, Barinoff J, Beckmann MW et al. Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018). GEBURTSH FRAUENHEILK. 2019 Okt;79(10):1060-1078. https://doi.org/10.1055/a-0919-4959

Bibtex

@article{cad2778f14fa4774aa09a95f2601527b,

title = "Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)",

abstract = "Purpose This is an official guideline, published and coordinated by the Gynecological Oncology Working Group (AGO) of the German Cancer Society (DKG) and the German Society for Gynecology and Obstetrics (DGGG). Vaginal cancers are rare tumors, which is why there is very little evidence on these tumors. Knowledge about the optimal clinical management is limited. This first German S2k guideline on vaginal cancer has aimed to compile the most current expert knowledge and offer new recommendations on the appropriate treatment as well as providing pointers about individually adapted therapies with lower morbidity rates than were previously generally available. The purpose of this guideline is also to set up a register to record data on treatment data and the course of disease as a means of obtaining evidence in future. Methods The present S2k guideline was developed by members of the Vulvar und Vaginal Tumors Commission of the AGO in an independently moderated, structured, formal consensus process and the contents were agreed with the mandate holders of the participating scientific societies and organizations. Recommendations To optimize the daily care of patients with vaginal cancer: 1. Monitor the spread pattern; 2. Follow the step-by-step diagnostic workup based on initial stage at detection; 3. As part of individualized clinical therapeutic management of vaginal cancer, follow the sentinel lymph node protocol described here, where possible; 4. Participate in the register study on vaginal cancer.",

author = "Hans-Georg Schn{\"u}rch and Sven Ackermann and Alt-Radtke, {Celine D} and Lukas Angleitner and Jana Barinoff and Beckmann, {Matthias W} and Carsten B{\"o}ing and Christian Dannecker and Tanja Fehm and R{\"u}diger Gaase and Paul Gass and Marion Gebhardt and Friederike Gieseking and Andreas G{\"u}nthert and Hack, {Carolin C} and Peer Hantschmann and Horn, {Lars Christian} and Koch, {Martin C} and Anne Letsch and Peter Mallmann and Bernhard Mangold and Simone Marnitz and Grit Mehlhorn and Kerstin Paradies and Reinhardt, {Michael J} and Reina Tholen and Uwe Torsten and Wolfgang Weikel and Linn W{\"o}lber and Monika Hampl",

note = "{\textcopyright} Thieme Medical Publishers.",

year = "2019",

month = oct,

doi = "10.1055/a-0919-4959",

language = "English",

volume = "79",

pages = "1060--1078",

journal = "GEBURTSH FRAUENHEILK",

issn = "0016-5751",

publisher = "Georg Thieme Verlag KG",

number = "10",

}

RIS

TY - JOUR

T1 - Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)

AU - Schnürch, Hans-Georg

AU - Ackermann, Sven

AU - Alt-Radtke, Celine D

AU - Angleitner, Lukas

AU - Barinoff, Jana

AU - Beckmann, Matthias W

AU - Böing, Carsten

AU - Dannecker, Christian

AU - Fehm, Tanja

AU - Gaase, Rüdiger

AU - Gass, Paul

AU - Gebhardt, Marion

AU - Gieseking, Friederike

AU - Günthert, Andreas

AU - Hack, Carolin C

AU - Hantschmann, Peer

AU - Horn, Lars Christian

AU - Koch, Martin C

AU - Letsch, Anne

AU - Mallmann, Peter

AU - Mangold, Bernhard

AU - Marnitz, Simone

AU - Mehlhorn, Grit

AU - Paradies, Kerstin

AU - Reinhardt, Michael J

AU - Tholen, Reina

AU - Torsten, Uwe

AU - Weikel, Wolfgang

AU - Wölber, Linn

AU - Hampl, Monika

PY - 2019/10

Y1 - 2019/10

N2 - Purpose This is an official guideline, published and coordinated by the Gynecological Oncology Working Group (AGO) of the German Cancer Society (DKG) and the German Society for Gynecology and Obstetrics (DGGG). Vaginal cancers are rare tumors, which is why there is very little evidence on these tumors. Knowledge about the optimal clinical management is limited. This first German S2k guideline on vaginal cancer has aimed to compile the most current expert knowledge and offer new recommendations on the appropriate treatment as well as providing pointers about individually adapted therapies with lower morbidity rates than were previously generally available. The purpose of this guideline is also to set up a register to record data on treatment data and the course of disease as a means of obtaining evidence in future. Methods The present S2k guideline was developed by members of the Vulvar und Vaginal Tumors Commission of the AGO in an independently moderated, structured, formal consensus process and the contents were agreed with the mandate holders of the participating scientific societies and organizations. Recommendations To optimize the daily care of patients with vaginal cancer: 1. Monitor the spread pattern; 2. Follow the step-by-step diagnostic workup based on initial stage at detection; 3. As part of individualized clinical therapeutic management of vaginal cancer, follow the sentinel lymph node protocol described here, where possible; 4. Participate in the register study on vaginal cancer.

AB - Purpose This is an official guideline, published and coordinated by the Gynecological Oncology Working Group (AGO) of the German Cancer Society (DKG) and the German Society for Gynecology and Obstetrics (DGGG). Vaginal cancers are rare tumors, which is why there is very little evidence on these tumors. Knowledge about the optimal clinical management is limited. This first German S2k guideline on vaginal cancer has aimed to compile the most current expert knowledge and offer new recommendations on the appropriate treatment as well as providing pointers about individually adapted therapies with lower morbidity rates than were previously generally available. The purpose of this guideline is also to set up a register to record data on treatment data and the course of disease as a means of obtaining evidence in future. Methods The present S2k guideline was developed by members of the Vulvar und Vaginal Tumors Commission of the AGO in an independently moderated, structured, formal consensus process and the contents were agreed with the mandate holders of the participating scientific societies and organizations. Recommendations To optimize the daily care of patients with vaginal cancer: 1. Monitor the spread pattern; 2. Follow the step-by-step diagnostic workup based on initial stage at detection; 3. As part of individualized clinical therapeutic management of vaginal cancer, follow the sentinel lymph node protocol described here, where possible; 4. Participate in the register study on vaginal cancer.

U2 - 10.1055/a-0919-4959

DO - 10.1055/a-0919-4959

M3 - SCORING: Journal article

C2 - 31680701

VL - 79

SP - 1060

EP - 1078

JO - GEBURTSH FRAUENHEILK

JF - GEBURTSH FRAUENHEILK

SN - 0016-5751

IS - 10

ER -